HCPCS Level IIdrugActive
J2186
Inj., meropenem, vaborbactam
BETOS: O1E
Effective: 2019-01-01
Description
Injection, meropenem and vaborbactam, 10mg/10mg (20mg)
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Vabomere
Manufacturer
Melinta Therapeutics, LLC
HCPCS Dosage
(10 MG/10MG) 20 MG
Billing Units
100.0000
1
NDC Products
opps
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.